68 results
Page 2 of 4
8-K
EX-99.3
dvfi7
20 Sep 21
Regulation FD Disclosure
8:01am
8-K
EX-99.3
jn9y7mnblo27e
12 Aug 21
Synlogic Reports Second Quarter Financial Results and Provides Business Update
10:18am
8-K
EX-99.1
kt3gky rlpr
15 Jul 21
Other Events
6:45am
424B5
dnvxc5e41vlao24u
19 Apr 21
Prospectus supplement for primary offering
4:06pm
8-K
EX-1.1
f677bq0mj7vpmw4e 42
16 Apr 21
Synlogic Announces Proposed Public Offering of Common Stock
8:35am
424B5
3nwf7
15 Apr 21
Prospectus supplement for primary offering
4:21pm
8-K
EX-99.2
l2mmwxttv9 25w
14 Apr 21
Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting
12:00am
8-K
EX-99.1
cs1c62dsb3y31bx m1dq
25 Mar 21
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:04am
8-K
EX-99.3
mg2wc7j95fdmrprhv00p
25 Mar 21
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:04am
8-K
EX-99.1
245b4ic
24 Mar 21
Synlogic Announces SYNB8802 Will Advance to Phase 1B Proof of Concept Study After Proof of Mechanism Demonstrated in Dietary Hyperoxaluria
4:59pm
8-K
EX-99.2
wv6t6fs 1l
5 Nov 20
Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of Enteric Hyperoxaluria
6:31am